[
    [
        {
            "time": "",
            "original_text": "涨了100倍，掌握3大极好资产，华兰生物，现在依然值得强力关",
            "features": {
                "keywords": [
                    "华兰生物",
                    "涨",
                    "100倍",
                    "极好资产"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "涨了100倍，掌握3大极好资产，华兰生物，现在依然值得强力关",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "华兰生物跌超6% 去年高点中信证券发研报喊买入",
            "features": {
                "keywords": [
                    "华兰生物",
                    "跌",
                    "6%",
                    "中信证券",
                    "研报",
                    "买入"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物跌超6% 去年高点中信证券发研报喊买入",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "新冠疫情影响下：流感疫苗“过冬天”",
            "features": {
                "keywords": [
                    "新冠疫情",
                    "流感疫苗",
                    "过冬天"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "新冠疫情影响下：流感疫苗“过冬天”",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-03-01",
            "original_text": "华兰生物：约515.29万股限售股3月1日解禁，占比0.2824% 解禁",
            "features": {
                "keywords": [
                    "华兰生物",
                    "限售股",
                    "解禁",
                    "3月1日"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物：约515.29万股限售股3月1日解禁，占比0.2824% 解禁",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华兰生物(002007.SZ)：515.2875万股限制性股票将解锁上市流通",
            "features": {
                "keywords": [
                    "华兰生物",
                    "限制性股票",
                    "解锁",
                    "上市流通"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物(002007.SZ)：515.2875万股限制性股票将解锁上市流通",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]